Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C017487 |
2-mercaptoacetate |
OPRK1 exon affects the susceptibility to 2-mercaptoacetate | affects response to substance | 10802031
|
C523979 |
3-(3-dimethylamino-1-ethyl-2-methylpropyl)phenol |
3-(3-dimethylamino-1-ethyl-2-methylpropyl)phenol binds to OPRK1 protein | affects binding | 17656655
|
D000081 |
Acetamides |
Acetamides analog binds to OPRK1 protein | affects binding | 16263278
|
D015081 |
2-Naphthylamine |
2-Naphthylamine results in decreased expression of OPRK1 mRNA | decreases expression | 18247414
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of OPRK1 mRNA | affects expression | 16483693
|
D001464 |
Barium |
3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer inhibits the reaction [OPRK1 protein results in increased transport of Barium] | decreases reaction|increases transport | 12031848
|
D001464 |
Barium |
OPRK1 protein affects the transport of Barium | affects transport | 12031848
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of OPRK1 mRNA | decreases expression | 18247414
|
D002713 |
Chlorine |
Chlorine results in decreased expression of OPRK1 mRNA | decreases expression | 18636392
|
D002713 |
Chlorine |
[Ozone co-treated with Chlorine] affects the expression of OPRK1 mRNA | affects cotreatment|affects expression | 18636392
|
D003513 |
Cycloheximide |
Cycloheximide results in increased expression of OPRK1 mRNA | increases expression | 19684285
|
D003513 |
Cycloheximide |
[Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of OPRK1 mRNA | affects cotreatment|increases expression | 19684285
|
D019900 |
3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer |
3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer inhibits the reaction [OPRK1 protein results in increased transport of Barium] | decreases reaction|increases transport | 12031848
|
D019900 |
3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer |
3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer binds to and results in increased activity of OPRK1 protein | affects binding|increases activity | 18562623
|
D004399 |
Dynorphins |
Dynorphins analog binds to OPRK1 protein | affects binding | 11270320
|
D004399 |
Dynorphins |
Dynorphins binds to and results in increased activity of OPRK1 protein | affects binding|increases activity | 11676193
|
D004399 |
Dynorphins |
norbinaltorphimine inhibits the reaction [Dynorphins binds to and results in increased activity of OPRK1 protein] | affects binding|decreases reaction|increases activity | 11676193
|
D000431 |
Ethanol |
Ethanol results in decreased expression of OPRK1 mRNA | decreases expression | 17934066
|
D000431 |
Ethanol |
fomepizole inhibits the reaction [Ethanol results in decreased expression of OPRK1 mRNA] | decreases expression|decreases reaction | 17934066
|
C010238 |
fomepizole |
fomepizole inhibits the reaction [Ethanol results in decreased expression of OPRK1 mRNA] | decreases expression|decreases reaction | 17934066
|
C106014 |
gedunin |
gedunin results in decreased expression of OPRK1 mRNA | decreases expression | 17010675
|
C058468 |
ICI 199441 |
ICI 199441 analog binds to and results in increased activity of OPRK1 protein | affects binding|increases activity | 15863335
|
C058468 |
ICI 199441 |
ICI 199441 binds to and results in increased activity of OPRK1 protein | affects binding|increases activity | 15863335
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in decreased expression of OPRK1 mRNA | decreases expression | 18977430
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in increased expression of OPRK1 mRNA | increases expression | 18977430
|
D009020 |
Morphine |
Morphine inhibits the reaction [Zymosan results in decreased expression of OPRK1 mRNA] | decreases expression|decreases reaction | 15979727
|
C058380 |
naloxone benzoylhydrazone |
naloxone benzoylhydrazone binds to and results in increased activity of OPRK1 protein | affects binding|increases activity | 11676193
|
C058380 |
naloxone benzoylhydrazone |
norbinaltorphimine inhibits the reaction [naloxone benzoylhydrazone binds to and results in increased activity of OPRK1 protein] | affects binding|decreases reaction|increases activity | 11676193
|
D009538 |
Nicotine |
Nicotine results in decreased expression of OPRK1 mRNA | decreases expression | 18247414
|
C051844 |
norbinaltorphimine |
norbinaltorphimine binds to and results in decreased activity of OPRK1 protein | affects binding|decreases activity | 15456805
|
C051844 |
norbinaltorphimine |
norbinaltorphimine inhibits the reaction [Dynorphins binds to and results in increased activity of OPRK1 protein] | affects binding|decreases reaction|increases activity | 11676193
|
C051844 |
norbinaltorphimine |
norbinaltorphimine inhibits the reaction [naloxone benzoylhydrazone binds to and results in increased activity of OPRK1 protein] | affects binding|decreases reaction|increases activity | 11676193
|
C051844 |
norbinaltorphimine |
norbinaltorphimine binds to and results in decreased activity of OPRK1 protein | affects binding|decreases activity | 16954126 10802031
|
D010126 |
Ozone |
Ozone results in increased expression of OPRK1 mRNA | increases expression | 12763052
|
D010126 |
Ozone |
[Ozone co-treated with Chlorine] affects the expression of OPRK1 mRNA | affects cotreatment|affects expression | 18636392
|
D010852 |
Picrotoxin |
Picrotoxin results in increased expression of OPRK1 mRNA | increases expression | 15170462
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of OPRK1 mRNA | affects cotreatment|increases expression | 19684285
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of OPRK1 mRNA | increases expression | 19684285
|
C050414 |
tripterine |
tripterine results in decreased expression of OPRK1 mRNA | decreases expression | 17010675
|
C111212 |
TRK 820 |
TRK 820 binds to and results in increased activity of OPRK1 protein | affects binding|increases activity | 16919318
|
C045444 |
U 69593 |
U 69593 binds to and results in increased activity of OPRK1 protein | affects binding|increases activity | 15456805
|
C045444 |
U 69593 |
U 69593 binds to and results in increased activity of OPRK1 protein | affects binding|increases activity | 16954126
|
D015054 |
Zymosan |
Zymosan results in decreased expression of OPRK1 mRNA | decreases expression | 18977430
|
D015054 |
Zymosan |
Morphine inhibits the reaction [Zymosan results in decreased expression of OPRK1 mRNA] | decreases expression|decreases reaction | 15979727
|
D015054 |
Zymosan |
Zymosan results in decreased expression of OPRK1 mRNA | decreases expression | 15979727
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Ethanol |
7.71 | 18926900 17676605 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
7.71 | 11752688 15322242 14514962 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
9.71 | 18287403 |
MESH:D000138 |
Acidosis |
|
Ethanol |
9.71 | 11192467 |
MESH:D055371 |
Acute Lung Injury |
|
Chlorine |
8.78 | 20601635 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
8.78 | 11850527 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
1.93 | 20127859 20464547 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.52 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.15 | 16835633 |
MESH:D020268 |
Alcohol-Induced Disorders, Nervous System |
|
Ethanol |
5.09 | 15451039 15451040 |
MESH:D000544 |
Alzheimer Disease |
|
Nicotine |
4.46 | 16627626 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
4.46 | 15513908 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
8.33 | 11748828 |
MESH:D000740 |
Anemia |
|
Zymosan |
8.33 | 18664788 |
MESH:D000853 |
Anophthalmos |
|
Ethanol |
4.59 | 15513904 |
MESH:D001008 |
Anxiety Disorders |
|
Ethanol |
3.83 | 11141031 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.85 | 19183758 |
MESH:D001169 |
Arthritis, Experimental |
|
Zymosan |
3.98 | 15142272 15188379 17659584 15944321 16872482 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
2.51 | 15570426 |
MESH:D001249 |
Asthma |
|
Ozone |
2.57 | 16373670 17854713 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
2.84 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.56 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.62 | 15746008 |
MESH:D002545 |
Brain Ischemia |
|
Morphine |
4.92 | 19211983 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
1.94 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.94 | 20435547 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.50 | 15516495 14754758 18417511 17626835 18315731 19059883 16777450 |
MESH:D002056 |
Burns |
|
Ethanol |
4.43 | 16374292 |
MESH:D002100 |
Cachexia |
|
Ozone |
4.51 | 16183385 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.62 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Ethanol |
2.37 | 15763234 18788625 15289165 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
1.99 | 20419170 |
MESH:D006332 |
Cardiomegaly |
|
Ethanol |
6.43 | 19332462 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
6.43 | 18850075 18670907 16120746 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.97 | 16835633 |
MESH:D002971 |
Cleft Lip |
|
Ethanol |
3.47 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Ethanol |
5.63 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.63 | 16354765 15340226 15668235 8697196 12621046 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.87 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Ethanol |
2.56 | 11873399 15451039 15513904 19302082 10194807 15451040 11198716 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.56 | 20055451 10048152 15322242 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.61 | 17107852 |
MESH:D003967 |
Diarrhea |
|
3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer |
8.66 | 2540324 |
MESH:D003967 |
Diarrhea |
|
Morphine |
8.66 | 2540324 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Ethanol |
3.71 | 11566570 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.71 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.59 | 11462148 |
MESH:D004417 |
Dyspnea |
|
Chlorine |
4.39 | 20016425 |
MESH:D020821 |
Dystonic Disorders |
|
Nicotine |
5.70 | 17881519 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.42 | 11000095 12711302 |
MESH:D004487 |
Edema |
|
Zymosan |
6.42 | 7907874 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.67 | 15322242 16714409 18230668 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.82 | 9294722 10568697 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
4.17 | 17637181 15821434 15328337 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.40 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Ethanol |
4.40 | 16704527 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.84 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Ethanol |
3.53 | 19236843 18620774 16409862 |
MESH:D005235 |
Fatty Liver, Alcoholic |
|
Ethanol |
5.43 | 17920746 |
MESH:D005310 |
Fetal Alcohol Syndrome |
|
Ethanol |
5.07 | 16946407 15451040 15513904 10194807 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.23 | 11858732 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
3.82 | 9205823 11852909 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
2.73 | 20067830 |
MESH:D005739 |
Gas Poisoning |
|
Chlorine |
4.78 | 20016425 |
MESH:D005756 |
Gastritis |
|
Ethanol |
4.46 | 15046732 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.36 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.05 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.05 | 10048152 11294989 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
4.19 | 16366002 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.13 | 11000095 |
MESH:D006505 |
Hepatitis |
|
Zymosan |
4.48 | 19110552 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.67 | 16120746 12621046 15340226 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.81 | 18606429 15340226 16354765 8697196 16959395 |
MESH:D006930 |
Hyperalgesia |
|
Ethanol |
3.54 | 18783367 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.82 | 18670907 18850075 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
7.80 | 12878042 17963957 17237260 9205823 17255318 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
7.80 | 12878042 12200463 |
MESH:D007249 |
Inflammation |
|
Zymosan |
7.80 | 11289658 8014878 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.42 | 17255318 |
MESH:D043183 |
Irritable Bowel Syndrome |
|
Zymosan |
5.61 | 17553498 |
MESH:D007569 |
Jaw Abnormalities |
|
Ethanol |
9.44 | 15513904 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
9.44 | 16580747 |
MESH:D007859 |
Learning Disorders |
|
Ethanol |
3.99 | 15451040 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
4.47 | 15821434 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Ethanol |
3.65 | 17676605 |
MESH:D008103 |
Liver Cirrhosis |
|
Ethanol |
3.25 | 15289165 |
MESH:D008104 |
Liver Cirrhosis, Alcoholic |
|
Ethanol |
4.87 | 18295389 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Ethanol |
3.43 | 18166357 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
3.43 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.43 | 12878042 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Ethanol |
4.43 | 17347304 17207112 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
4.04 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.04 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
1.97 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
3.23 | 19066396 8266340 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
8.49 | 21114838 |
MESH:D055370 |
Lung Injury |
|
Ozone |
8.49 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
3.24 | 20135361 18569708 17053015 20464547 20064080 18816296 6695378 20869020 18520028 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
3.24 | 7614698 8597069 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.24 | 11884234 19555203 |
MESH:D008569 |
Memory Disorders |
|
Ethanol |
3.97 | 15451040 18411066 |
MESH:D008679 |
Metaplasia |
|
Ozone |
4.87 | 10496685 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.02 | 16381670 |
MESH:D009102 |
Multiple Organ Failure |
|
Zymosan |
4.99 | 15213630 12130978 15834315 18160304 17724436 15259001 10890648 10479408 15241586 12879239 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.84 | 12213967 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
5.04 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Nicotine |
5.04 | 16365874 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Nicotine |
4.77 | 16365874 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.00 | 14600291 |
MESH:D010146 |
Pain |
|
3-(3-dimethylamino-1-ethyl-2-methylpropyl)phenol |
11.12 | 17656655 |
MESH:D010146 |
Pain |
|
3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer |
11.12 | 18699797 |
MESH:D010146 |
Pain |
|
Morphine |
11.12 | 15275824 16273134 20225289 18699797 15215642 6776300 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Ethanol |
2.89 | 12384795 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.02 | 12520081 |
MESH:D010538 |
Peritonitis |
|
Ozone |
9.67 | 16369182 |
MESH:D010538 |
Peritonitis |
|
Zymosan |
9.67 | 18557954 17371808 18760300 15979727 14761945 19641140 19088179 18977430 15259001 17826846 11985352 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
10.34 | 11605937 12224865 |
MESH:D011014 |
Pneumonia |
|
Ozone |
10.34 | 18381685 18929643 18007984 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.34 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
2.96 | 11118676 11399792 11222880 11896295 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
3.04 | 17292933 |
MESH:D011537 |
Pruritus |
|
TRK 820 |
6.64 | 16919318 |
MESH:D015427 |
Reperfusion Injury |
|
Morphine |
4.02 | 19211983 |
MESH:D012120 |
Respiration Disorders |
|
Chlorine |
4.98 | 18579056 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.58 | 10835634 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.62 | 18990726 |
MESH:D012640 |
Seizures |
|
Ethanol |
9.35 | 9754883 |
MESH:D012640 |
Seizures |
|
Nicotine |
9.35 | 17873105 |
MESH:D012640 |
Seizures |
|
Picrotoxin |
9.35 | 8954991 8635557 |
MESH:D018805 |
Sepsis |
|
Zymosan |
4.46 | 11441115 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
5.12 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.12 | 16192470 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.47 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
Ethanol |
2.47 | 18456281 |
MESH:D013276 |
Stomach Ulcer |
|
Ethanol |
3.33 | 9211565 16755016 9562338 11906479 17189318 17918041 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Ethanol |
4.06 | 9754883 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
3.97 | 15821434 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.67 | 12697716 |
OMIM:188890 |
TOBACCO ADDICTION, SUSCEPTIBILITY TO |
|
Nicotine |
4.56 | 16785264 16720336 11259349 |
MESH:D014029 |
Tobacco Use Disorder |
|
Nicotine |
5.22 | 17979512 18305452 18041664 15735609 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2-Naphthylamine |
5.20 | 11144890 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
5.20 | 17053015 |
MESH:D014605 |
Uveitis |
|
Zymosan |
5.17 | 11006244 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.36 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.02 | 15886252 |